Publication | Closed Access

Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice

Metabolic SyndromeSignal TransductionNovel Ptp1b InhibitorBiochemistryMedicineDiabetesMetabolic RegulationDiabetes MellitusInsulin-resistance Hepg2 CellsPharmacologyCell BiologyCell SignalingDiabetic Kkay MiceInsulin Signaling